News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,158 Results
Type
Article (28829)
Company Profile (65)
Press Release (374264)
Section
Business (109329)
Career Advice (492)
Deals (17800)
Drug Delivery (52)
Drug Development (48557)
Employer Resources (52)
FDA (13071)
Job Trends (8859)
News (194451)
Policy (20551)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1836)
Accelerated approval (1)
Adcomms (9)
Allergies (66)
Alliances (28276)
ALS (49)
Alzheimer's disease (829)
Antibody-drug conjugate (ADC) (37)
Approvals (13094)
Artificial intelligence (148)
Autoimmune disease (6)
Automation (5)
Bankruptcy (153)
Best Places to Work (7215)
BIOSECURE Act (5)
Biosimilars (33)
Biotechnology (43)
Bladder cancer (40)
Brain cancer (15)
Breast cancer (164)
Cancer (1176)
Cardiovascular disease (98)
Career advice (442)
Career pathing (13)
CAR-T (60)
Cell therapy (184)
Cervical cancer (9)
Clinical research (40899)
Collaboration (395)
Compensation (104)
Complete response letters (11)
COVID-19 (1536)
CRISPR (10)
C-suite (106)
Cystic fibrosis (41)
Data (1237)
Decentralized trials (2)
Denatured (16)
Depression (26)
Diabetes (158)
Diagnostics (3768)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (47)
Drug pricing (53)
Drug shortages (21)
Duchenne muscular dystrophy (38)
Earnings (38528)
Editorial (18)
Employer branding (7)
Employer resources (49)
Events (53872)
Executive appointments (388)
FDA (13883)
Featured Employer (17)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (361)
Gene editing (31)
Generative AI (11)
Gene therapy (117)
GLP-1 (391)
Government (3092)
Grass and pollen (3)
Guidances (33)
Healthcare (12634)
Huntington's disease (9)
IgA nephropathy (12)
Immunology and inflammation (33)
Indications (17)
Infectious disease (1595)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (21)
Intellectual property (41)
Interviews (49)
IPO (7382)
IRA (20)
Job creations (1945)
Job search strategy (407)
Kidney cancer (7)
Labor market (7)
Layoffs (171)
Leadership (3)
Legal (3948)
Liver cancer (54)
Lung cancer (195)
Lymphoma (77)
Machine learning (1)
Management (17)
Manufacturing (95)
MASH (38)
Medical device (13410)
Medtech (13414)
Mergers & acquisitions (10657)
Metabolic disorders (381)
Multiple sclerosis (42)
NASH (12)
Neurodegenerative disease (38)
Neuropsychiatric disorders (9)
Neuroscience (1108)
NextGen: Class of 2025 (4154)
Non-profit (2915)
Northern California (1158)
Now hiring (16)
Obesity (201)
Opinion (75)
Ovarian cancer (40)
Pain (57)
Pancreatic cancer (44)
Parkinson's disease (82)
Partnered (11)
Patents (91)
Patient recruitment (63)
Peanut (36)
People (35573)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (11741)
Phase II (17710)
Phase III (14564)
Pipeline (469)
Podcasts (22)
Policy (45)
Postmarket research (1695)
Preclinical (3663)
Press Release (20)
Prostate cancer (63)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (166)
Real estate (2995)
Recruiting (18)
Regulatory (14830)
Reports (16)
Research institute (1651)
Resumes & cover letters (53)
Rett syndrome (2)
RNA editing (1)
RSV (16)
Schizophrenia (42)
Series A (61)
Series B (41)
Service/supplier (3)
Sickle cell disease (20)
Southern California (1010)
Special edition (4)
Sponsored (14)
Startups (2255)
Stomach cancer (8)
Supply chain (32)
The Weekly (6)
United States (11311)
Vaccines (330)
Venture capitalists (12)
Webinars (8)
Weight loss (135)
Women's health (17)
Worklife (4)
Date
Today (105)
Last 7 days (415)
Last 30 days (1591)
Last 365 days (20087)
2025 (3496)
2024 (20657)
2023 (23620)
2022 (32272)
2021 (34543)
2020 (33781)
2019 (29944)
2018 (22992)
2017 (20172)
2016 (19593)
2015 (22821)
2014 (17424)
2013 (14481)
2012 (15638)
2011 (15926)
2010 (14292)
Location
Africa (378)
Alabama (20)
Alaska (2)
Arizona (118)
Arkansas (11)
Asia (25434)
Australia (4059)
California (2622)
Canada (1133)
China (294)
Colorado (149)
Connecticut (154)
Delaware (93)
Europe (50622)
Florida (484)
Georgia (117)
Idaho (37)
Illinois (321)
India (12)
Indiana (206)
Iowa (2)
Japan (94)
Kansas (69)
Kentucky (12)
Louisiana (5)
Maine (29)
Maryland (576)
Massachusetts (1910)
Michigan (119)
Minnesota (245)
Mississippi (2)
Missouri (47)
Montana (19)
Nebraska (20)
Nevada (29)
New Hampshire (58)
New Jersey (968)
New Mexico (10)
New York (825)
North Carolina (521)
North Dakota (3)
Northern California (1158)
Ohio (122)
Oklahoma (4)
Oregon (23)
Pennsylvania (727)
Puerto Rico (4)
Rhode Island (19)
South America (546)
South Carolina (14)
Southern California (1010)
Tennessee (63)
Texas (452)
Utah (99)
Virginia (68)
Washington D.C. (35)
Washington State (204)
West Virginia (3)
Wisconsin (34)
403,158 Results for "apollo medical devices".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India
March 4, 2025
·
3 min read
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
Press Releases
Alzheon Announces Two New Scientific Papers Ahead of APOLLOE4 Phase 3 Trial Topline Symposium at ADPD Conference in Vienna on April 1st, Marking 15 Pathbreaking Peer-Reviewed Publications from Alzheon
February 25, 2025
·
11 min read
Corin Group Announces Clinical Use of Apollo™ Robotic-Assisted Surgical Platform
Corin Group, a pioneer in orthopaedic innovation, announced the successful completion of first cases using the Apollo™ platform and ApolloKnee™ software for robotic-assisted total knee arthroplasty.
May 2, 2024
·
2 min read
Deals
Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Apollo Medical Holdings, Inc. today announced that effective on January 23, 2024, the Compensation Committee of ApolloMed’s Board of Directors (the “Committee”) granted 85,130 shares of time-based restricted common stock and 65,265 shares of performance-based restricted common stock to Dinesh M. Kumar, M.D., the Company’s newly-hired Chief Medical Officer, under the Apollo Medical Holdings, Inc. Employment Inducement Award Plan (the “Inducement Plan”).
January 24, 2024
·
3 min read
Biotech Beach
Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - December 18, 2023
Apollo Medical Holdings, Inc. announced that effective on December 15, 2023, the Compensation Committee of ApolloMed’s Board of Directors granted a total of 38,779 shares of restricted common stock to eight newly-hired non-executive employees, under the Apollo Medical Holdings, Inc. Employment Inducement Award Plan.
December 18, 2023
·
2 min read
Drug Development
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
Marker Therapeutics, Inc. reported that Geoffrey Shouse, D.O., Ph.D., the Principal Investigator at City of Hope National Medical Center in Duarte, CA, was invited to present his clinical experience from the APOLLO study at the 11th Global Summit on Hematologic Malignancies in Whistler, BC, Canada.
April 8, 2024
·
8 min read
Biotech Beach
Apollo Medical Holdings, Inc. to Participate in Upcoming November 2023 Investor Conference
Apollo Medical Holdings, Inc. announced that leadership is participating in the BTIG Digital Health Forum, being held virtually, on Monday, November 20, 2023, including a panel discussion with Brandon Sim, Co-Chief Executive Officer, at 12:00 p.m. PT/3:00 p.m. ET.
November 13, 2023
·
1 min read
Business
Apollo Medical Holdings, Inc. Schedules 2023 Third Quarter Financial Results Release and Conference Call
Apollo Medical Holdings, Inc. announced that it will release financial results for the third quarter ended September 30, 2023, after the close of the stock market on Tuesday, November 7, 2023.
October 19, 2023
·
2 min read
Deals
Apollo Medical Holdings, Inc. Announces Definitive Agreement to Acquire Assets of Community Family Care Medical Group IPA, Inc. and Health Plan
Apollo Medical Holdings, Inc. announced that it and its affiliated professional entity have entered into a definitive agreement to acquire assets relating to Community Family Care Medical Group IPA, Inc., including the CFC independent physician association, the CFC Health Plan and CFC’s management services organization entities.
November 7, 2023
·
5 min read
1 of 40,316
Next